Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Johnson & johnson crawled time : 12:20 save search
PaxMedica Appoints David Hough M.D. as Chief Medical Officer
Published: 2023-08-16 (Crawled : 12:20) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
PXMD | $0.7235 -3.83% -3.98% 710K
|
Health Technology
|
| O: -1.88%
H: 0.0%
C: -2.72%
medical
Pfizer Bispecific Drug Wins FDA Accelerated Approval for Multiple Myeloma
Published: 2023-08-15 (Crawled : 12:20) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.82%
H: 0.0%
C: 0.0%
fda drug approval
FDA Approves J&J’s Akeega for BRCA-Positive Prostate Cancer
Published: 2023-08-14 (Crawled : 12:20) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.86%
H: 0.0%
C: 0.0%
fda cancer
Perosphere Technologies Appoints Michelle Brennan to Board of Directors
Published: 2023-08-02 (Crawled : 12:20) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 1.28%
H: 0.0%
C: 0.0%
Biopharma Lawsuit Tracker 2023: J&J Ordered to Plaintiff $18.8M in Talc Suit
Published: 2023-07-20 (Crawled : 12:20) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 2.02%
H: 4.45%
C: 3.98%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.2%
H: 0.7%
C: 0.27%
biopharma
Royalty Pharma to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
Published: 2023-06-07 (Crawled : 12:20) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.05%
H: 0.44%
C: 0.27%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: -0.35%
H: 0.44%
C: 0.21%
pharma conference royalty global
Milestone Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Corporate Update
Published: 2023-05-11 (Crawled : 12:20) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.11%
H: 0.22%
C: -0.52%
SPPI | $1.03 -0.97% 0
|
Health Technology
|
| O: -1.56%
H: 7.94%
C: 3.97%
MIST | $1.67 2.45% 2.4% 90K
|
Health Technology
|
| O: -2.31%
H: 13.91%
C: 11.55%
MRNS | $1.455 -1.36% -1.37% 2.9M
|
Health Technology
|
| O: 2.51%
H: 0.0%
C: -5.7%
AGRX | $0.394 0.0% 16K
|
Health Technology
|
| O: 0.68%
H: 1.02%
C: -3.57%
update pharmaceuticals financial results milestone
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
Published: 2023-04-27 (Crawled : 12:20) - biospace.com/
TSVT | $4.63 -0.43% -0.43% 290K
|
|
| O: 0.71%
H: 8.58%
C: 5.64%
XYF | News | $3.882 -0.46% 0.0% 340
|
Finance
|
| O: -3.13%
H: 3.23%
C: 1.94%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.17%
H: 0.31%
C: 0.06%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -0.6%
financial results
Open Book Extracts Announces Allen Olson as VP of Supply Chain
Published: 2023-04-25 (Crawled : 12:20) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.38%
H: 0.63%
C: 0.53%
Leyden Labs’ Intranasal PanFlu Antibody Enters the Clinic
Published: 2023-04-19 (Crawled : 12:20) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.61%
H: 0.43%
C: 0.33%
antibody
Royalty Pharma Declares Second Quarter 2023 Dividend
Published: 2023-04-17 (Crawled : 12:20) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.06%
H: 0.3%
C: -0.04%
RPRX | $27.82 0.0% 3.5M
|
Health Technology
|
| O: -0.06%
H: 0.94%
C: 0.88%
pharma royalty
DIGITAL THERAPEUTICS STARTUP RESPIREE™ ANNOUNCES RESIDENCY AT JLABS @ SHANGHAI
Published: 2023-04-10 (Crawled : 12:20) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.31%
H: 0.13%
C: -0.19%
therapeutics
Northpass Launches First of a Kind Resources to Help Companies Scale Customer Success Through Digital Customer Education
Published: 2023-04-10 (Crawled : 12:20) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.31%
H: 0.13%
C: -0.19%
companies success education
Nexcella, an Immix Biopharma Subsidiary, Announces 2023 Haematologica Editorial Highlighting NXC-201 Efficacy In The Context of U.S. Food And Drug Administration Approved BCMA CAR T Cells
Published: 2023-03-31 (Crawled : 12:20) - globenewswire.com
IMMX | $2.32 8.92% 8.19% 80K
|
|
| O: 2.33%
H: 6.24%
C: 3.41%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.23%
H: 0.91%
C: 0.79%
nxc-201 drug approved food biopharma
INSTITUTE FOR SUPPLY MANAGEMENT® HONORS 30 UNDER 30 RISING SUPPLY CHAIN STARS
Published: 2023-03-22 (Crawled : 12:20) - prnewswire.com
X | $37.94 -2.32% 0.0% 3.8M
|
Non-Energy Minerals
|
| O: 0.04%
H: 0.83%
C: -2.59%
NOC | $474.68 0.79% 0.0% 1.4M
|
Electronic Technology
|
| O: 0.05%
H: 0.48%
C: -1.47%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.03%
H: 0.14%
C: -1.82%
management
TREMFYA® (guselkumab) Real-World Data Analyses Show Greater Treatment Persistence Than IL-17s in Both Bio-naïve and Bio-experienced Patients Living With Moderate to Severe Plaque Psoriasis
Published: 2023-03-17 (Crawled : 12:20) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.29%
H: 0.3%
C: -1.36%
il-17 tremfya psoriasis treatment living show
AC Immune Reports Full Year 2022 Financial Results and Provides Corporate Update
Published: 2023-03-16 (Crawled : 12:20) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.58%
H: 0.6%
C: 0.38%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -0.56%
H: 1.24%
C: 0.58%
ACIU | $2.38 -1.65% -1.68% 190K
|
Health Technology
|
| O: 0.0%
H: 6.09%
C: 0.43%
year update financial results
Flagship Pioneering Announces Appointment of Christian Schade as Growth Partner
Published: 2023-01-31 (Crawled : 12:20) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: -1.05%
H: 0.0%
C: 0.0%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.19%
H: 1.07%
C: 1.06%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -1.22%
H: 0.52%
C: 0.51%
growth
Lipid Based Formulations Global Market Report 2023: Featuring Novartis, AbbVie, F. Hoffmann-La Roche, Johnson & Johnson, Alnylam Pharmaceuticals & More
Published: 2023-01-27 (Crawled : 12:20) - prnewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.56%
H: 0.73%
C: 0.17%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.21%
H: 0.19%
C: -0.18%
pharmaceuticals global report market
Insights on the Hip Replacement Global Market to 2028 - Industry Trends, Growth, Impact of Inflation, Opportunities and Company Analysis
Published: 2023-01-25 (Crawled : 12:20) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.68%
H: 1.4%
C: 1.4%
global impact market
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.